Health Benefits Innovation: Delivering Better Patient Care includes Preemptive Strategies

About ALVA-10 For far too long there has been a gap between payers and diagnostic companies where diagnostic technology has been characterized as “expensive and unnecessary”, because it has been poorly understood, undervalued and underutilized. Alva10 was established in response to this divide. With years of experience in pharmaceutical and diagnostic companies, Founders Hannah Mamuszka and Lena Chaihorsky built a team and company dedicated to narrowing that knowledge gap. Armed with and driven by knowledge, curiosity and a passion to innovate the industry, Alva10 set out to redesign the healthcare system while restructuring current spiraling healthcare spend. Read more about how Alva10 was founded here. Alva10 reduces ineffective therapeutic spend through customized solutions that provide advanced knowledge of patients’ ability to respond to costly therapies before they are given. Through our proprietary model M.A.T.E. we restructure the relationship between health insurance payers and Precision Medicine diagnostic companies. The result of this new way of doing business is a broad range of completely novel healthcare tools that directly solve the large clinical and economic challenges for payers and providers.  Lena Chaihorsky | Co-Founder ALVA-10 Lena is the co-founder and Vice President of Payer Innovation at Alva10. With a background in biology and mathematics from Tufts, she is a skilled healthcare executive with a proven track record of developing and executing value based reimbursement strategies for diagnostics companies. Lena has extensive leadership experience in sales, national contracting, and all aspects of reimbursement within start-up and global companies, most recently AmniSure and QIAGEN. Lena also contributes to Alva10’s public speaking and writing efforts, leveraging her unique perspective on payer business and innovation models and their intersections with the diagnostics industry. Her work on commercial approaches to health economics data analysis led to her appointment as co-chair of the World Economic Forum’s workgroup dedicated to the economics of rare disease data federations in 2019. She is active within the Tufts Alumni Career Networking Community, and both a mentor and mentee within the HLTH Foundation’s CSweetener , a 501(c) 3 charity working toward healthcare equality, diversity and access by empowering women to seek and obtain mentorship from industry leaders. About PBGH - Pittsburgh Business Group on Health Since the 1980s, the Pittsburgh Business Group on Health has been driving change in healthcare – giving a voice to employers in their efforts to contain rising costs for care and prescription drugs that are suppressing the ability of their employees to receive the care they need when they need at a price they can afford. More than 100 leading employers from across southwestern Pennsylvania enjoy the benefits of and solutions provided by PBGH – one of the nation’s leading non-profit organizations dedicated to helping companies protect and promote their ability to provide high-quality, equitable and affordable healthcare for their employees. From award-winning prescription drug containment initiatives to nationally renowned educational programs for human resources, benefits managers and C-suite officers, PBGH delivers the comprehensive cost-savings and health and wellness solutions companies need today to drive and implement change in healthcare. PBGH’s targeted voice advocates for employers at the highest local, state and federal levels – lobbying and pursuing real transformation in the way healthcare is delivered and paid for so companies and organizations have the power to be competitive and succeed so our region thrives. Jessica Brooks | President & CEO PBGH Learn more about your ad choices. Visit megaphone.fm/adchoices